Polycystic ovarian syndrome (PCOS) is the most common multifactor heterogeneous
endocrine and metabolic disease in women of childbearing age. PCOS is a group of clinical …

Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder among
women of reproductive age. Current standard treatment includes lifestyle change, oral …

Polycystic ovary syndrome (PCOS) is a multifactorial endocrinopathy of indistinguishable
etiopathogenesis that is liable to entail genetic and environmental machinery synergistically …

Research question What role do ADIPOQ variants play in controlling adiponectin
concentrations and altered risk of polycystic ovary syndrome (PCOS)? Design Study …

Purpose To evaluate the genetic variants related to polycystic ovary syndrome (PCOS) and
its metabolic complications in girls born small for gestational age (SGA). Design …

Objective Polycystic ovary syndrome (PCOS) is prevalent among reproductive-aged women
and is categorized by hormonal imbalances, irregular menstrual cycles, and challenges with …

Background: Polycystic ovary syndrome (PCOS) is a leading cause of infertility. Insulin
resistance is a key element in pathogenesis. The insulin receptor causes phosphorylation of …

Polycystic ovary syndrome (PCOS) is a complex endocrinopathy in women of reproductive
age. The genetics of PCOS is heterogeneous with the involvement of number of genes in the …

This study was conducted to investigate the possible association of the single nucleic
polymorphisms (SNPs) in the interleukin-17F precursor gene (IL17A) gene with asthma. This …